Stock quote - Summary

Avacta Group
AVCT: 19.00 0.00 ( 0.00 %) delayed: 17:32PM
Bid price 18.50 High price 0.00
Ask price 19.00 Low price 0.00
Open price 0.00 Spread 0.00%
Prev close 18.75 Volume 0

Avacta Group - Share price charts

Historic - 6 months

Advanced Avacta Group charts >

Avacta Group - Share price information
Name Avacta Group Epic AVCT
Activities Avacta Group plc's (formerly Readybuy plc) principal focus is on its proprietary Affimer technology which is a novel engineered alternative to antibodies that has wide application in Life Sciences for diagnostics, therapeutics and general research and development. Antibodies dominate markets worth in excess of $100bn despite their shortcomings. Affimer technology has been designed to address many of these negative performance issues, principally; the time taken to generate new antibodies, the reliance on an animal's immune response, poor specificity in many cases, and batch to batch variability. Affimer technology is based on a small protein that can be quickly generated to bind with high specificity and affinity to a wide range of protein targets. Avacta has a pre-clinical biotech development programme with an in-house focus on immuno-oncology as well as partnered development programmes. Avacta is commercialising non-therapeutic Affimer reagents through licensing to developers of life sciences research tools and diagnostics. ISIN GB00BYYW9G87
Latest Share Price (p) 0.00 Net Gearing (%) -16.40
Market Capitalisation (pm) 32.99 Gross Gearing (%) 8.90
Shares in issue (m) 175.94 Debt Ratio 0.00
P/E Ratio -2.14 Debt-to-Equity Ratio 0.00
Total dividends per share (p) 0.00 Assets / Equity Ratio 1.10
Dividend Yield (%) 0.00 Price to book value 1.41
Dividend Cover 0.00 ROCE (%) -47.48
Earning per share (p) -8.76 EPS Growth (%) 35.06
52-week high / low (p) 49.00 / 15.13 DPS Growth (%) n/a
Avacta Group - Broker views
Date Broker Recommendation Price Old target price New target price Notes
23 Jan finnCap Corporate 76.00 - Reiterates
13 Nov finnCap Corporate 76.00 - Reiterates
21 Oct finnCap Corporate 76.00 - Reiterates
10 Oct finnCap Corporate 125.00 - Reiterates
20 Jun finnCap Corporate 125.00 - Reiterates

More Avacta Group broker views >

Avacta Group - Director deals
Date Director Type Volume / Price Trade value
22 Nov 2019 Dr Trevor Nicholls Buy 107,455 @ 17.50p £18,804.63
22 Nov 2019 Dr Trevor Nicholls Sell 108,333 @ 17.50p £18,958.28
02 Jan 2019 Tony Gardiner Buy 8,196 @ 30.50p £2,499.78
13 Mar 2018 Prof Alastair Smith Buy 35,800 @ 41.92p £15,007.36
21 Aug 2017 Prof Alastair Smith Buy 33,225 @ 74.50p £24,752.63

More Avacta Group director deals >

Risk warning: Remember the price of shares can go down as well as up, and you are not guaranteed to get back the amount that you originally invested.
Click here to read the full warning.